| 000 | 01750 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516064642.0 | ||
| 264 | 0 | _c20120213 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1520-4995 | ||
| 024 | 7 |
_a10.1021/bi2013855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathea, Sebastian | |
| 245 | 0 | 0 |
_aSuppression of EGFR autophosphorylation by FKBP12. _h[electronic resource] |
| 260 |
_bBiochemistry _cDec 2011 |
||
| 300 |
_a10844-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntibodies, Phospho-Specific |
| 650 | 0 | 4 |
_aCarcinoma _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCross-Linking Reagents |
| 650 | 0 | 4 | _aDimerization |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRecombinant Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTacrolimus Binding Protein 1A _xantagonists & inhibitors |
| 700 | 1 | _aLi, Sen | |
| 700 | 1 | _aSchierhorn, Angelika | |
| 700 | 1 | _aJahreis, Günther | |
| 700 | 1 | _aSchiene-Fischer, Cordelia | |
| 773 | 0 |
_tBiochemistry _gvol. 50 _gno. 50 _gp. 10844-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi2013855 _zAvailable from publisher's website |
| 999 |
_c21330569 _d21330569 |
||